Cargando…
A Narrative Review of Acthar Gel for the Treatment of Myositis
Idiopathic inflammatory myopathies (IIMs) are autoimmune disorders characterized by symmetric proximal muscle weakness and chronic inflammation, with an increased risk of morbidity and mortality. The current standard of care includes traditional immunosuppressive pharmacotherapies; however, some pat...
Autores principales: | Chandra, Tanya, Aggarwal, Rohit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140234/ https://www.ncbi.nlm.nih.gov/pubmed/36966453 http://dx.doi.org/10.1007/s40744-023-00545-1 |
Ejemplares similares
-
Sarcoidosis patient with lupus pernio and infliximab-induced myositis: Response to Acthar gel
por: Zhou, Ying, et al.
Publicado: (2015) -
Acthar Gel (RCI): A Narrative Literature Review of Clinical and Economic Evidence
por: Wan, George J, et al.
Publicado: (2023) -
Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series
por: Madan, Arvind, et al.
Publicado: (2016) -
Acthar(®) Gel Treatment for Patients with Autoimmune and Inflammatory Diseases: An Historical Perspective and Characterization of Clinical Evidence
por: Kaplan, Jeffrey, et al.
Publicado: (2023) -
Acthar Gel Inhibits the Activation of CD4(+) and CD8(+) T Cells
por: Wright, Dale, et al.
Publicado: (2023)